Sanofi to acquire Principia Biopharma
The deal adds to Sanofi’s R&D areas of autoimmune and allergic diseases
Author
India’s CMO market is hotbed for global PE investment: GlobalData
Indian pharma companies are more likely to engage in contract/excess capacity API manufacture than companies in the other small…
US FDA approves Enspryng from Genentech for neuromyelitis optica spectrum disorder
In two randomised controlled Phase III clinical trials, SAkuraStar and SAkuraSky studies, Enspryng demonstrated robust and…
Sai Life Sciences opens Research & Technology Centre in Hyderabad
The company, through an initiative named Sai Nxt, is investing over $150 million (> Rs 1000 crores) to expand and upgrade its…
COVID-19 disrupted clinical trials with suspended enrollment more likely to resume: GlobalData
The number of trials that have been impacted by slow enrollment has increased by 13.9 per cent
Roadmap to distribute COVID-19 vaccines to Indians is ready: PM Modi
Three potential indigenous vaccines under development and as soon as scientists give the go-ahead, the country is ready for mass…
Government-funded Centre for Biopharma Analysis set up in Pune
It has numerous high-end instrumentation facilities worth Rs 10 crore and is expected to fast track research under biopharma in…
Lupin presents Phase 3 data for Solosec in female patients with trichomoniasis
The company plans to submit a supplemental New Drug Application for Solosec to the FDA for the treatment of trichomoniasis later…
Atrimed Pharma claims breakthrough in molecule research for COVID-19 cure
Reportedly, three of its samples tested positive against SARS-CoV-2 in an ICMR-designated laboratory
Lee Pharma to launch favipiravir under brand name Faravir at Rs 27 per tablet
It has got DCGI nod to manufacture and market favipiravir APIs